Table of Content
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Anthelmintic Drugs Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Anthelmintic Drugs Market Analysis and Forecast, 2018–2030
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Epidemiology of Helminthic Infections
5.2. Key Industry Events (Product Launch, Approval, Acquisition, Merger, Collaboration, etc.)
5.3. Impact of COVID-19 on Anthelmintic Drugs Market
6. Global Anthelmintic Drugs Market Analysis and Forecast, by Drug Class
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018–2030
6.3.1. Benzimidazoles
6.3.2. Piperazine
6.3.3. Others
6.4. Market Attractiveness Analysis, by Drug Class
7. Global Anthelmintic Drugs Market Analysis and Forecast, by Route of Administration
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018–2030
7.3.1. Oral
7.3.2. Injectable
7.4. Market Attractiveness Analysis, by Route of Administration
8. Global Anthelmintic Drugs Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Anthelmintic Drugs Market Value Forecast, by Application, 2018–2030
8.3.1. Human
8.3.1.1. Parenchymal Neurocysticercosis
8.3.1.2. Gastrointestinal Infections
8.3.2. Animal
8.4. Market Attractiveness Analysis, by Application
9. Global Anthelmintic Drugs Market Analysis and Forecast, by Target Pathogen
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018–2030
9.3.1. Ascaris Lumbricoides (Roundworm)
9.3.2. Trichuris Trichiura (Whipworm
9.3.3. Enterobius Vermicularis (Pinworm)
9.3.4. Ancylostoma Duodenale (Hookworm)
9.3.5. Others
9.4. Market Attractiveness Analysis, by Target Pathogen
10. Global Anthelmintic Drugs Market Analysis and Forecast, by Distribution Channel
10.1. Introduction & Definition
10.2. Key Findings / Developments
10.3. Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018–2030
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Online Pharmacies
10.3.4. Veterinary Pharmacies
10.3.5. Veterinary Hospitals & Clinics
10.4. Market Attractiveness Analysis, by Distribution Channel
11. Global Anthelmintic Drugs Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Anthelmintic Drugs Market Value Forecast, by Region
11.2.1. Europe
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness Analysis, by Region
12. North America Anthelmintic Drugs Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. North America Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018–2030
12.2.1. Benzimidazoles
12.2.2. Piperazine
12.2.3. Others
12.3. North America Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018–2030
12.3.1. Oral
12.3.2. Injectable
12.4. North America Anthelmintic Drugs Market Value Forecast, by Application, 2018–2030
12.4.1. Human
12.4.1.1. Parenchymal Neurocysticercosis
12.4.1.2. Gastrointestinal Infections
12.4.2. Animal
12.5. North America Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018–2030
12.5.1. Ascaris Lumbricoides (Roundworm)
12.5.2. Trichuris Trichiura (Whipworm
12.5.3. Enterobius Vermicularis (Pinworm)
12.5.4. Ancylostoma Duodenale (Hookworm)
12.5.5. Others
12.6. North America Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018–2030
12.6.1. Hospital Pharmacies
12.6.2. Retail Pharmacies
12.6.3. Online Pharmacies
12.6.4. Veterinary Pharmacies
12.6.5. Veterinary Hospitals & Clinics
12.7. North America Anthelmintic Drugs Market Value Forecast, by Country, 2018–2030
12.7.1. U.S.
12.7.2. Canada
12.8. North America Anthelmintic Drugs Market Attractiveness Analysis
12.8.1. By Drug Class
12.8.2. By Route of Administration
12.8.3. By Application
12.8.4. By Target Pathogen
12.8.5. By Distribution Channel
12.8.6. By Country
13. Europe Anthelmintic Drugs Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Europe Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018–2030
13.2.1. Benzimidazoles
13.2.2. Piperazine
13.2.3. Others
13.3. Europe Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018–2030
13.3.1. Oral
13.3.2. Injectable
13.4. Europe Anthelmintic Drugs Market Value Forecast, by Application, 2018–2030
13.4.1. Human
13.4.1.1. Parenchymal Neurocysticercosis
13.4.1.2. Gastrointestinal Infections
13.4.2. Animal
13.5. Europe Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018–2030
13.5.1. Ascaris Lumbricoides (Roundworm)
13.5.2. Trichuris Trichiura (Whipworm
13.5.3. Enterobius Vermicularis (Pinworm)
13.5.4. Ancylostoma Duodenale (Hookworm)
13.5.5. Others
13.6. Europe Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018–2030
13.6.1. Hospital Pharmacies
13.6.2. Retail Pharmacies
13.6.3. Online Pharmacies
13.6.4. Veterinary Pharmacies
13.6.5. Veterinary Hospitals & Clinics
13.7. Europe Anthelmintic Drugs Market Value Forecast, by Country/Sub-region, 2018–2030
13.7.1. Germany
13.7.2. U.K.
13.7.3. France
13.7.4. Spain
13.7.5. Italy
13.7.6. Rest of Europe
13.8. Europe Anthelmintic Drugs Market Attractiveness Analysis
13.8.1. By Drug Class
13.8.2. By Route of Administration
13.8.3. By Application
13.8.4. By Target Pathogen
13.8.5. By Distribution Channel
13.8.6. By Country/Sub-region
14. Asia Pacific Anthelmintic Drugs Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018–2030
14.2.1. Benzimidazoles
14.2.2. Piperazine
14.2.3. Others
14.3. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018–2030
14.3.1. Oral
14.3.2. Injectable
14.4. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Application, 2018–2030
14.4.1. Human
14.4.1.1. Parenchymal Neurocysticercosis
14.4.1.2. Gastrointestinal Infections
14.4.2. Animal
14.5. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018–2030
14.5.1. Ascaris Lumbricoides (Roundworm)
14.5.2. Trichuris Trichiura (Whipworm
14.5.3. Enterobius Vermicularis (Pinworm)
14.5.4. Ancylostoma Duodenale (Hookworm)
14.5.5. Others
14.6. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018–2030
14.6.1. Hospital Pharmacies
14.6.2. Retail Pharmacies
14.6.3. Online Pharmacies
14.6.4. Veterinary Pharmacies
14.6.5. Veterinary Hospitals & Clinics
14.7. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Country/Sub-region, 2018–2030
14.7.1. China
14.7.2. Japan
14.7.3. India
14.7.4. Australia & New Zealand
14.7.5. Rest of Asia Pacific
14.8. Asia Pacific Anthelmintic Drugs Market Attractiveness Analysis
14.8.1. By Drug Class
14.8.2. By Route of Administration
14.8.3. By Application
14.8.4. By Target Pathogen
14.8.5. By Distribution Channel
14.8.6. By Country/Sub-region
15. Latin America Anthelmintic Drugs Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Latin America Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018–2030
15.2.1. Benzimidazoles
15.2.2. Piperazine
15.2.3. Others
15.3. Latin America Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018–2030
15.3.1. Oral
15.3.2. Injectable
15.4. Latin America Anthelmintic Drugs Market Value Forecast, by Application, 2018–2030
15.4.1. Human
15.4.1.1. Parenchymal Neurocysticercosis
15.4.1.2. Gastrointestinal Infections
15.4.2. Animal
15.5. Latin America Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018–2030
15.5.1. Ascaris Lumbricoides (Roundworm)
15.5.2. Trichuris Trichiura (Whipworm
15.5.3. Enterobius Vermicularis (Pinworm)
15.5.4. Ancylostoma Duodenale (Hookworm)
15.5.5. Others
15.6. Latin America Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018–2030
15.6.1. Hospital Pharmacies
15.6.2. Retail Pharmacies
15.6.3. Online Pharmacies
15.6.4. Veterinary Pharmacies
15.6.5. Veterinary Hospitals & Clinics
15.7. Latin America Anthelmintic Drugs Market Value Forecast, by Country/Sub-region, 2018–2030
15.7.1. Brazil
15.7.2. Mexico
15.7.3. Rest of Latin America
15.8. Latin America Anthelmintic Drugs Market Attractiveness Analysis
15.8.1. By Drug Class
15.8.2. By Route of Administration
15.8.3. By Application
15.8.4. By Target Pathogen
15.8.5. By Distribution Channel
15.8.6. By Country/Sub-region
16. Middle East & Africa Anthelmintic Drugs Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018–2030
16.2.1. Benzimidazoles
16.2.2. Piperazine
16.2.3. Others
16.3. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018–2030
16.3.1. Oral
16.3.2. Injectable
16.4. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Application, 2018–2030
16.4.1. Human
16.4.1.1. Parenchymal Neurocysticercosis
16.4.1.2. Gastrointestinal Infections
16.4.2. Animal
16.5. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018–2030
16.5.1. Ascaris Lumbricoides (Roundworm)
16.5.2. Trichuris Trichiura (Whipworm
16.5.3. Enterobius Vermicularis (Pinworm)
16.5.4. Ancylostoma Duodenale (Hookworm)
16.5.5. Others
16.6. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018–2030
16.6.1. Hospital Pharmacies
16.6.2. Retail Pharmacies
16.6.3. Online Pharmacies
16.6.4. Veterinary Pharmacies
16.6.5. Veterinary Hospitals & Clinics
16.7. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Country/Sub-region, 2018–2030
16.7.1. GCC Countries
16.7.2. South Africa
16.7.3. Rest of Middle East & Africa
16.8. Middle East & Africa Anthelmintic Drugs Market Attractiveness Analysis
16.8.1. By Drug Class
16.8.2. By Route of Administration
16.8.3. By Application
16.8.4. By Target Pathogen
16.8.5. By Distribution Channel
16.8.6. By Country/Sub-region
17. Competitive Landscape
17.1. Market Player – Competition Matrix (By Tier and Size of companies)
17.2. Company Profiles
17.2.1. Novartis AG
17.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.1.2. Financial Overview
17.2.1.3. Product Portfolio
17.2.1.4. Strategic Overview
17.2.1.5. SWOT Analysis
17.2.2. Zoetis, Inc.
17.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.2.2. Financial Overview
17.2.2.3. Product Portfolio
17.2.2.4. Strategic Overview
17.2.2.5. SWOT Analysis
17.2.3. Amneal Pharmaceuticals Inc.
17.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.3.2. Financial Overview
17.2.3.3. Product Portfolio
17.2.3.4. Strategic Overview
17.2.3.5. SWOT Analysis
17.2.4. Cipla Inc.
17.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.4.2. Financial Overview
17.2.4.3. Product Portfolio
17.2.4.4. Strategic Overview
17.2.4.5. SWOT Analysis
17.2.5. Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
17.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.5.2. Financial Overview
17.2.5.3. Product Portfolio
17.2.5.4. Strategic Overview
17.2.5.5. SWOT Analysis
17.2.6. Sun Pharmaceutical Industries Ltd
17.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.6.2. Financial Overview
17.2.6.3. Product Portfolio
17.2.6.4. Strategic Overview
17.2.6.5. SWOT Analysis
17.2.7. GlaxoSmithKline plc
17.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.7.2. Financial Overview
17.2.7.3. Product Portfolio
17.2.7.4. Strategic Overview
17.2.7.5. SWOT Analysis
17.2.8. Bayer AG
17.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.8.2. Financial Overview
17.2.8.3. Product Portfolio
17.2.8.4. Strategic Overview
17.2.8.5. SWOT Analysis
17.2.9. Merck & Co. Inc. (Intervet Inc.)
17.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.9.2. Financial Overview
17.2.9.3. Product Portfolio
17.2.9.4. Strategic Overview
17.2.9.5. SWOT Analysis
17.2.10. Boehringer Ingelheim International GmbH
17.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
17.2.10.2. Financial Overview
17.2.10.3. Product Portfolio
17.2.10.4. Strategic Overview
17.2.10.5. SWOT Analysis
List of Figures
Figure 01: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y (%) Forecast, 2018–2030
Figure 02: Global Anthelmintic Drugs Market Value Share, by Drug Class, 2019
Figure 03: Global Anthelmintic Drugs Market Value Share, by Route of Administration, 2019
Figure 05: Global Anthelmintic Drugs Market Value Share, by Target Pathogen, 2019
Figure 04: Global Anthelmintic Drugs Market Value Share, by Application, 2019
Figure 06: Global Anthelmintic Drugs Market Value Share, by Distribution Channel, 2019
Figure 07: Global Anthelmintic Drugs Market Value Share, by Region, 2019
Figure 08: North America Anthelmintic Drugs Market - Prevalence
Figure 09: North America Anthelmintic Drugs Market - Prevalence
Figure 10: Asia Pacific Anthelmintic Drugs Market - Prevalence
Figure 11: Latin America Anthelmintic Drugs Market - Prevalence
Figure 12: Middle East & Africa Anthelmintic Drugs Market - Prevalence
Figure 13: Key Industry Developments – Anthelmintic Drugs Market
Figure 14: Global Anthelmintic Drugs Market Value Share Analysis, by Drug Class, 2019 and 2030
Figure 15: Global Anthelmintic Drugs Market Attractiveness Analysis, by Drug Class, 2020–2030
Figure 16: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Benzimidazoles, 2020–2030
Figure 17: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Piperazine, 2020–2030
Figure 18: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2020–2030
Figure 19: Global Anthelmintic Drugs Market Value Share Analysis, by Route of Administration, 2019 and 2030
Figure 20: Global Anthelmintic Drugs Market Attractiveness Analysis, by Route of Administration, 2020–2030
Figure 21: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Oral, 2020–2030
Figure 22: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Injectable, 2020–2030
Figure 23: Global Anthelmintic Drugs Market Value Share Analysis, by Application, 2019 and 2030
Figure 24: Global Anthelmintic Drugs Market Attractiveness Analysis, by Application, 2020–2030
Figure 25: Global Anthelmintic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Human, 2020–2030
Figure 26: Global Anthelmintic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Animal, 2020–2030
Figure 27: Global Anthelmintic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Parenchymal Neurocysticercosis, 2020–2030
Figure 28: Global Anthelmintic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Gastrointestinal Infections, 2020–2030
Figure 29: Global Anthelmintic Drugs Market Value Share Analysis, by Target Pathogen, 2019 and 2030
Figure 30: Global Anthelmintic Drugs Market Attractiveness Analysis, by Target Pathogen, 2020–2030
Figure 31: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Ascaris Lumbricoides (Roundworm), 2020–2030
Figure 32: Global Anthelmintic Drugs Market value (US$ Mn) and Y-o-Y Growth (%), by Trichuris Trichiura (Whipworm), 2020–2030
Figure 33: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Enterobius Vermicularis (Pinworm), 2020–2030
Figure 34: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Ancylostoma Duodenale (Hookworm), 2020–2030
Figure 35: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2020–2030
Figure 36: Global Anthelmintic Drugs Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 37: Global Anthelmintic Drugs Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 38: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2020–2030
Figure 39: Global Anthelmintic Drugs Market value (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2020–2030
Figure 40: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2020–2030
Figure 41: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Veterinary Pharmacies, 2020–2030
Figure 42: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Veterinary Hospitals and Clinics, 2020–2030
Figure 43: Global Anthelmintic Drugs Market Value Share Analysis, by Region, 2019 and 2030
Figure 44: Global Anthelmintic Drugs Market Attractiveness Analysis, by Region, 2020–2030
Figure 45: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018?2030
Figure 46: North America Anthelmintic Drugs Market Value Share Analysis, by Country, 2019 and 2030
Figure 47: North America Anthelmintic Drugs Market Attractiveness Analysis, by Country, 2020–2030
Figure 48: North America Anthelmintic Drugs Market Value Share Analysis, by Drug Class, 2019 and 2030
Figure 49: North America Anthelmintic Drugs Market Attractiveness Analysis, by Drug Class, 2020–2030
Figure 50: North America Anthelmintic Drugs Market Value Share Analysis, by Route Of Administration, 2019 and 2030
Figure 51: North America Anthelmintic Drugs Market Attractiveness Analysis, by Route Of Administration, 2020–2030
Figure 52: North America Anthelmintic Drugs Market Value Share Analysis, by Application, 2019 and 2030
Figure 53: North America Anthelmintic Drugs Market Attractiveness Analysis, by Application, 2020–2030
Figure 54: North America Anthelmintic Drugs Market Value Share Analysis, by Target Pathogen, 2019 and 2030
Figure 55: North America Anthelmintic Drugs Market Attractiveness Analysis, by Target Pathogen, 2020–2030
Figure 56: North America Anthelmintic Drugs Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 57: North America Anthelmintic Drugs Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 58: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018?2030
Figure 59: Europe Anthelmintic Drugs Market Value Share Analysis, by Country, 2019 and 2030
Figure 60: Europe Anthelmintic Drugs Market Attractiveness Analysis, by Country, 2020–2030
Figure 61: Europe Anthelmintic Drugs Market Value Share Analysis, by Drug Class, 2019 and 2030
Figure 62: Europe Anthelmintic Drugs Market Attractiveness Analysis, by Drug Class, 2020–2030
Figure 63: Europe Anthelmintic Drugs Market Value Share Analysis, by Route Of Administration, 2019 and 2030
Figure 64: Europe Anthelmintic Drugs Market Attractiveness Analysis, by Route Of Administration, 2020–2030
Figure 65: Europe Anthelmintic Drugs Market Value Share Analysis, by Application, 2019 and 2030
Figure 66: Europe Anthelmintic Drugs Market Attractiveness Analysis, by Application, 2020–2030
Figure 67: Europe Anthelmintic Drugs Market Value Share Analysis, by Target Pathogen, 2019 and 2030
Figure 68: Europe Anthelmintic Drugs Market Attractiveness Analysis, by Target Pathogen, 2020–2030
Figure 69: Europe Anthelmintic Drugs Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 70: Europe Anthelmintic Drugs Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 71: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 72: Asia Pacific Anthelmintic Drugs Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 73: Asia Pacific Anthelmintic Drugs Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 74: Asia Pacific Anthelmintic Drugs Market Value Share Analysis, by Drug Class, 2019 and 2030
Figure 75: Asia Pacific Anthelmintic Drugs Market Attractiveness Analysis, by Drug Class, 2020–2030
Figure 76: Asia Pacific Anthelmintic Drugs Market Value Share Analysis, by Route of Administration, 2019 and 2030
Figure 77: Asia Pacific Anthelmintic Drugs Market Attractiveness Analysis, by Route of Administration, 2020–2030
Figure 78: Asia Pacific Anthelmintic Drugs Market Value Share Analysis, by Application, 2019 and 2030
Figure 79: Asia Pacific Anthelmintic Drugs Market Attractiveness Analysis, by Application, 2020–2030
Figure 80: Asia Pacific Anthelmintic Drugs Market Value Share Analysis, by Target Pathogen, 2019 and 2030
Figure 81: Asia Pacific Anthelmintic Drugs Market Attractiveness Analysis, by Target Pathogen, 2020–2030
Figure 82: Asia Pacific Anthelmintic Drugs Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 83: Asia Pacific Anthelmintic Drugs Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 84: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
Figure 85: Latin America Anthelmintic Drugs Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 86: Latin America Anthelmintic Drugs Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 87: Latin America Anthelmintic Drugs Market Value Share Analysis, by Drug Class, 2019 and 2030
Figure 88: Latin America Anthelmintic Drugs Market Attractiveness Analysis, by Drug Class, 2020–2030
Figure 89: Latin America Anthelmintic Drugs Market Value Share Analysis, by Route of Administration, 2019 and 2030
Figure 90: Latin America Anthelmintic Drugs Market Attractiveness Analysis, by Route of Administration, 2020–2030
Figure 91: Latin America Anthelmintic Drugs Market Value Share Analysis, by Application, 2019 and 2030
Figure 92: Latin America Anthelmintic Drugs Market Attractiveness Analysis, by Application, 2020–2030
Figure 93: Latin America Anthelmintic Drugs Market Value Share Analysis, by Target Pathogen, 2019 and 2030
Figure 94: Latin America Anthelmintic Drugs Market Attractiveness Analysis, by Target Pathogen, 2020–2030
Figure 95: Latin America Anthelmintic Drugs Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 96: Latin America Anthelmintic Drugs Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 97: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
Figure 98: Middle East & Africa Anthelmintic Drugs Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 99: Middle East & Africa Anthelmintic Drugs Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 100: Middle East & Africa Anthelmintic Drugs Market Value Share Analysis, by Drug Class, 2019 and 2030
Figure 101: Middle East & Africa Anthelmintic Drugs Market Attractiveness Analysis, by Drug Class, 2020–2030
Figure 102: Middle East & Africa Anthelmintic Drugs Market Value Share Analysis, by Route of Administration, 2019 and 2030
Figure 103: Middle East & Africa Anthelmintic Drugs Market Attractiveness Analysis, by Route of Administration, 2020–2030
Figure 104: Middle East & Africa Anthelmintic Drugs Market Value Share Analysis, by Application, 2019 and 2030
Figure 105: Middle East & Africa Anthelmintic Drugs Market Attractiveness Analysis, by Application, 2020–2030
Figure 106: Middle East & Africa Anthelmintic Drugs Market Value Share Analysis, by Target Pathogen, 2019 and 2030
Figure 107: Middle East & Africa Anthelmintic Drugs Market Attractiveness Analysis, by Target Pathogen, 2020–2030
Figure 108: Middle East & Africa Anthelmintic Drugs Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 109: Middle East & Africa Anthelmintic Drugs Market Attractiveness Analysis, by Distribution Channel, 2020–2030
List of Tables
Table 01: Europe Anthelmintic Drugs Market - Prevalence
Table 02: Europe Anthelmintic Drugs Market - Prevalence
Table 03: Global Anthelmintic Drugs Market Forecast, by Drug Class
Table 04: Global Anthelmintic Drugs Market Forecast, by Route of Administration
Table 05: Global Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Application, 2020–2030
Table 06: Global Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Human, 2020–2030
Table 07: Global Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Target Pathogen, 2018-2030
Table 08: Global Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 09: Global Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Region, 2018-2030
Table 10: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Country, 2018?2030
Table 11: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2018?2030
Table 12: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Route of Administration, 2018?2030
Table 13: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Application, 2018?2030
Table 14: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Human, 2018?2030
Table 15: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Target Pathogen, 2018?2030
Table 16: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018?2030
Table 17: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018?2030
Table 18: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2018?2030
Table 19: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Route Of Administration, 2018?2030
Table 20: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Application, 2018?2030
Table 21: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Human, 2018?2030
Table 22: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Target Pathogen, 2018?2030
Table 23: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018?2030
Table 24: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 25: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030
Table 26: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Route Of Administration, 2018–2030
Table 27: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 28: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Human Application, 2018–2030
Table 29: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Target Pathogen, 2018–2030
Table 30: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 31: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 32: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030
Table 33: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 34: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 35: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Human, 2018–2030
Table 36: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Target Pathogen, 2018–2030
Table 37: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 38: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 39: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030
Table 40: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030
Table 41: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 42: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Human, 2018–2030
Table 43: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Target Pathogen, 2018–2030
Table 44: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
US $
Euro €
GBP £